News From SDEE Members

Or sign in with email

    Please check your e-mail for a link to activate your account.

    Allele Bio Awarded 2 NIH Grants

    Allele Biotechnology and Pharmaceuticals is pleased to announce receiving NIH grants to develop antibody therapies for Alzheimer's Disease and to develop a novel manufacturing system producing stem cells for clinical therapy.  Allele Biotechnology and Pharmaceuticals, Inc. is a private, San Diego-based company that explores the mechanisms of biological processes to develop technologies...
    Read more

    Neuropore Therapies (NPT) Announces Achievement of $5 Million Milestone with UCB Collaboration

    SAN DIEGO, September 13, 2016 -- Neuropore Therapies, Inc. (NPT) announced today that they have successfully achieved a key program milestone in their collaboration with UCB.  After successful completion of a randomized, double-blind, placebo controlled single ascending dose clinical study and additional non-clinical studies, UCB has awarded NPTTM a progression milestone...
    Read more

    Get the Newsletter

    Crinetics Pharmaceuticals Appoints Ajay Madan as VP, Development

    Crinetics Pharmaceuticals announced the addition of Ajay Madan, PhD, DABT, as the Vice President of Development. Dr. Madan has a distinguished career in drug development as former VP of Preclinical Development at Neurocrine Biosciences and CSO at XenoTech. “It’s exciting to join the company at such a crucial time as we...
    Read more

    Reveal Biosciences and Explora BioLabs Awarded NIA Contract

    Congratulations to SDEE members Reveal Biosciences and Explora BioLabs on receiving a National Institute on Aging (NIA) contract to to develop and maintain an Aged Rodent Tissue Bank. This is a prestigious contract award from the NIA, a National Institutes of Health agency supporting research on aging and Alzheimer's disease research....
    Read more

    Flow Paradigm Moving to New Facility

    Flow Paradigm and its subsidiaries, nanoBioforms and FloCyte recently announced they are moving to a new facility in San Diego. "This move gives us greater access to companion technologies which provides more value to our clients. Work will not stop during the move, so keep the experiments coming." - Dana...
    Read more

    Used Lab Equipment Available

    ThermoForma 3860 CO2 incubator Nuaire Labgard 6' TC hood VWR Symphony pH meter with 2 probes Barnstead Nanopure Diamond ultra-purification water system  Thermo Smartpure ultra-purification water system Beckman Microfuge 18 Thermolyne Cimarec3 magnetic stir plate with heat element Sterilaire UV lamp If interested please contact Rob at 310-926-6159 or email...
    Read more

    Reveal Biosciences Moves to New Facility

    Congratulations to Reveal Biosciences, LLC on their continued success in the San Diego community. Founder and CEO, Claire Weston PhD first bootstrapped the company in 2012 after she "identified a strong need for a high quality contract research organization focusing on tissue-based research". Reveal Biosciences has grown quickly since then, recently announcing...
    Read more

    Charles River Laboratories Announces Agreement to Acquire WIL Research

    Charles River Laboratories announced on January 7, 2016 the signing of a definitive agreement to acquire WIL Research. This acquisition will "enhance Charles River’s global footprint, scientific capabilities, and access to growing end markets, which provides a compelling value proposition for both clients and shareholders".  Charles River Laboratories is an early...
    Read more

    Reveal Biosciences Partners with Affymetrix for RNA Biomarker Services

    Reveal Biosciences announced a partnership agreement with Affymetrix that will enable Reveal to offer new RNA biomarker validation services. Reveal will use Affymetrix ViewRNA ISH products combined with their proprietary ImageDx software to provide RNA in situ hybridization (ISH) staining, imaging and quantification services.  “We are thrilled to partner with...
    Read more

    Become a Member

    Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat.

    Learn More